Overall, our results support the view that the higher plasma levels of BCAAs detected in obesity/insulin resistance ob/ob mice are a consequence of reduced protein expression of BCAA metabolism enzymes in liver and white adipose tissue, and occur in the absence of alterations in skeletal muscle. Here, ARID4B is linked to obesity disorder.